文献速递流行病学与生物统计真实世界研究与卫生经济

替代方法确定治疗指征的最优风险阈值:冠心病示例

An alternative approach identified optimal risk thresholds for treatment indication: an illustration in coronary heart disease.
PubMed 文献 · J Clin Epidemiol · 2017-10-03

该研究提出一种基于健康经济模型和边际分析的通用方法,用于识别优化个体健康(经济)结局的治疗阈值,并以基于Framingham风险评分预测10年冠心病风险的他汀治疗为例进行演示。通过逐步降低风险阈值(从20%降至0%)并比较临床及健康经济结局,发现将他汀诱导并发症的人群水平比例控制在<10%时,男性阈值为6%、女性为2%;仅考虑QALYs时,男性阈值可降至1%、女性降至0%;同时考虑成本时,男性净健康效益在阈值3%时仍有利,女性为6%。作者认为该逐步风险优化方法有助于决策者制定治疗阈值。

要点

  • 提出基于健康经济模型和边际分析的风险阈值优化通用方法。
  • 示例中控制他汀并发症<10%对应阈值男性6%、女性2%。
  • 仅优化QALYs时阈值可降至男性1%、女性0%。

核心结论

  • 使用逐步基于风险的方法优化阈值,可实现优化结局的预防策略。
  • 呈现全面的结局概览将更好地为决策者定义治疗阈值提供信息。

研究设计与样本

  • 研究设计为创建健康经济模型评估基于风险预防策略,并以Markov模型模拟冠心病,风险阈值从20%逐步降至0%进行评价。
  • 示例基于Framingham风险评分预测的10年冠心病风险,评估他汀治疗阈值。

主要发现

  • 将他汀诱导并发症的人群水平比例控制在<10%时,得到阈值男性T=6%、女性T=2%。
  • 每降低1%阈值比较质量调整生命年(QALYs),QALYs获益持续至男性T=1%、女性T=0%。
  • 同时考虑成本后,净健康效益在男性T=3%、女性T=6%时仍有利。

关键数值与推荐

  • 并发症限制<10%对应阈值:男性T=6%,女性T=2%。
  • QALYs优化对应阈值:男性T=1%,女性T=0%。
  • 净健康效益有利对应阈值:男性T=3%,女性T=6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Treatment thresholds based on risk predictions can be optimized by considering various health (economic) outcomes and performing marginal analyses, but this is rarely performed. We demonstrate a general approach to identify treatment thresholds optimizing individual health (economic) outcomes, illustrated for statin treatment based on 10-year coronary heart disease (CHD) risk predicted by the Framingham risk score. STUDY DESIGN AND SETTING: Creating a health economic model for a risk-based prevention strategy, risk thresholds can be evaluated on several outcomes of interest. Selecting an appropriate threshold range and decrement size for the thresholds and adapting the health economic model accordingly, outcomes can be calculated for each risk threshold. A stepwise, or marginal, comparison of clinical as well as health economic outcomes, that is, comparing outcomes using a specific threshold to outcomes of the former threshold while gradually lowering the threshold, then takes into account the balance between additional numbers of individuals treated and their outcomes (additional health effects and costs). In our illustration, using a Markov model for CHD, we evaluated risk thresholds by gradually lowering thresholds from 20% to 0%. RESULTS: This approach can be applied to identify optimal risk thresholds on any outcome, such as to limit complications, maximize health outcomes, or optimize cost-effectiveness. In our illustration, keeping the population-level fraction of statin-induced complications <10% resulted in thresholds of T = 6% (men) and T = 2% (women). Lowering the threshold and comparing quality-adjusted life-years (QALYs) after each 1% decrease, QALYs were gained down to T = 1% (men) and T = 0% (women). Also accounting for costs, net health benefits were favorable down to T = 3% (men) and T = 6% (women). CONCLUSION: Using a stepwise risk-based approach to threshold optimization allows for preventive strategies that optimize outcomes. Presenting this comprehensive overview of outcomes will better inform decision makers when defining a treatment threshold.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. van Giessen A, de Wit GA, Moons KGM, et al. An alternative approach identified optimal risk thresholds for treatment indication: an illustration in coronary heart disease. J Clin Epidemiol. 2017. PMID: 28986242. doi:10.1016/j.jclinepi.2017.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。